https://www.selleckchem.com/products/mm-102.html
Acute lung injury (ALI), acute respiratory distress syndrome (ARDS) and pulmonary fibrosis remain major causes of morbidity, mortality and a healthcare burden in critically ill patient. There is an urgent need to identify factors causing susceptibility and for the design of new therapeutic agents. Here, we evaluate the effectiveness of the immunomodulatory neuropeptide cortistatin to regulate pulmonary inflammation and fibrosis in vivo. ALI/ARDS and pulmonary fibrosis were induced experimentally in wild-type and cortistatin-deficient mic
Like
Comment
Share
